U.S. House Energy and Commerce (E&C) Chair Frank Pallone (D-N.J.) last Friday formally announced Rep. Anna Eshoo (D-Calif.) as Health subcommittee chair and Rep. Diana DeGette (D-Colo.) as leader of the Oversight and Investigations subcommittee.
Eshoo, who is based
…340B Report’s content including full articles is now available exclusively for paid subscribers. For those who have already paid, we sincerely thank you. If you have any questions about logging in, please contact Reshma Eggleston at reshma.eggleston@340Breport.com
For those who have not
Drug manufacturer Gilead has altered a planned change to its patient assistance program (PAP) for uninsured people living with HIV that would have been unworkable for some vulnerable patients, HIV/AIDS caregivers and activists say. The change also would have deprived
…
Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar last week asked a federal district judge to dismiss a lawsuit against him and his department by 340B hospitals over HHS’s enforcement of its 340B contract pharmacy requirements for drug
…
U.S. insulin manufacturer and pharmacy benefit manager (PBM) business practices “have created a vicious cycle of price increases that have sent costs for patients and taxpayers through the roof,” U.S. Senate Finance Committee leaders Chuck Grassley (R-Iowa) and Ron Wyden
…
Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma both referred to 340B—obliquely in Azar’s case, directly in Verma’s—in recent farewell remarks.
In an interview with Modern Healthcare
…
National health care organizations and businesses with major stakes in the 340B program have suspended political contributions following a pro-Trump mob’s Jan. 6 violent attack on Congress to stop it from counting and certifying the Electoral College’s votes for president.
…SPONSORED CONTENT by Jim Jorgenson, CEO, Visante
2020 was a year like no other! Dominated by challenges and uncertainty with the pandemic and the economy, and the political landscape overshadowing everything.
As always, and particularly in the face of rising challenges, we would like to thank our many clients for trusting us to support their organizations and to help them weather the storm as we head into what will hopefully be a better 2021.
As we look ahead, as in years past, we are pleased to offer our insight and perspective on what we think will be the Top 10 items for pharmacy to consider in 2021. There is no doubt many of the challenges we face now will continue into 2021, but with big challenges also come big opportunities and we are very heartened and optimistic about the capability of pharmacy to step up and be a solution for many of these challenges. In 2021, we see expanded opportunities for pharmacy to take a greater leadership role and make larger organizational contributions to quality, safety and finances.
As
…We hope you are enjoying 340B Report’s new website and email platform that we launched yesterday. If you or a colleague did not receive the issue in your in-box, please make sure to mark us as a safe sender and add
The National Association of Community Health Centers (NACHC) last night on its members’ behalf asked a new federal 340B program administrative dispute resolution (ADR) panel to order drug manufacturers Eli Lilly and Co., Sanofi, and AstraZeneca to lift all “qualifications,
…*Sign up for news summaries and alerts from 340B Report
